Net income 2017
Net income 2018
P/E ratio 2017
P/E ratio 2018
EV / Sales2017
EV / Sales2018
6 078 M
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology.It operates its business through the Ionis Core and Akcea Therapeutics segments.The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline...
Surperformance© ratings of ISIS Pharmaceuticals, Inc.
Trading Rating :
Investor Rating :
Latest news on ISIS PHARMACEUTICALS, INC.
Sector news : Biotechnology & Medical Research - NEC
4-Traders Strategies on ISIS PHARMACEUTICALS, INC.
Chart ISIS PHARMACEUTICALS, INC.
Number of Analysts
Average target price
Spread / Average Target